Theravance Biopharma, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Theravance Biopharma, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2013 to Q2 2024.
  • Theravance Biopharma, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $7.73M, a 33.3% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.73M -$3.86M -33.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.9M -$4.2M -34.7% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $8.07M +$1.17M +16.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $10M +$5.13M +106% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $11.6M +$8.28M +251% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $12.1M +$8.9M +279% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $6.9M +$3.67M +114% Dec 31, 2022 10-K 2024-03-01
Q3 2022 $4.87M +$1.57M +47.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.3M +$1.98M +149% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $3.19M +$890K +38.6% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $3.23M +$777K +31.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $3.3M +$2.49M +307% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.33M -$183K -12.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $2.3M +$996K +76.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.45M +$861K +54.2% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $810K -$495K -37.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $1.51M +$120K +8.65% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.31M -$131K -9.1% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $1.59M +$56K +3.65% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $1.31M -$457K -25.9% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.39M -$378K -21.4% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $1.44M -$366K -20.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $1.53M -$349K -18.5% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $1.76M -$344K -16.3% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $1.77M -$3.28M -65% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $1.81M +$239K +15.3% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $1.88M -$10K -0.53% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $2.11M -$3.71M -63.8% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $5.05M +$3.64M +260% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.57M +$743K +90.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.89M +$815K +75.6% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $5.82M +$4.9M +532% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $1.4M +$386K +38% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $823K +$137K +20% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.08M +$572K +113% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $921K Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $1.02M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $686K Mar 31, 2015 10-Q 2015-05-13
Q4 2014 $506K +$506K Dec 31, 2014 10-K 2016-03-11
Q4 2013 $0 Dec 31, 2013 10-K 2015-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.